Platelet reactivity is associated with pump thrombosis in patients with left ventricular assist devices

Patients with left ventricular assist devices (LVADs) are treated with a potent antithrombotic regimen to prevent pump thrombosis and thromboembolism. High on-treatment residual platelet reactivity (HRPR) is associated with ischemic outcomes in cardiovascular disease. In the current study, we invest...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Research and practice in thrombosis and haemostasis 2024-08, Vol.8 (6), p.102564, Article 102564
Hauptverfasser:	Mutschlechner, David, Tscharre, Maximilian, Wittmann, Franziska, Kitzmantl, Daniela, Schlöglhofer, Thomas, Wadowski, Patricia Pia, Laufer, Günther, Eichelberger, Beate, Lee, Silvia, Wiedemann, Dominik, Panzer, Simon, Zimpfer, Daniel, Gremmel, Thomas
Format:	Artikel
Sprache:	eng
Schlagworte:	bleeding complications heart failure high on-treatment residual platelet reactivity left ventricular assist devices Original pump thrombosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!